‘Most-Favored-Nation’ price scheme will allow Americans to bypass middlemen and buy directly from drug companies, reducing costs across the board.
‘Most-Favored-Nation’ price scheme will allow Americans to bypass middlemen and buy directly from drug companies, reducing costs across the board.
